$XNCR
Xencor Inc

2020 Q2 Form 10-Q Financial Statement

#000155837020009191 Filed on August 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $13.10M $19.49M
YoY Change -32.77%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.200M $5.800M
YoY Change 24.14% 16.0%
% of Gross Profit
Research & Development $43.46M $33.30M
YoY Change 30.51% 42.72%
% of Gross Profit
Depreciation & Amortization $1.400M $1.000M
YoY Change 40.0% 11.11%
% of Gross Profit
Operating Expenses $50.69M $39.06M
YoY Change 29.78% 38.06%
Operating Profit -$37.60M -$19.57M
YoY Change 92.11% -30.82%
Interest Expense $2.100M $3.600M
YoY Change -41.67% 44.0%
% of Operating Profit
Other Income/Expense, Net $2.582M $3.588M
YoY Change -28.04% 48.2%
Pretax Income -$35.02M -$15.98M
YoY Change 119.08% -38.21%
Income Tax $0.00 $50.00K
% Of Pretax Income
Net Earnings -$35.02M -$16.03M
YoY Change 118.4% -38.02%
Net Earnings / Revenue -267.31% -82.29%
Basic Earnings Per Share -$0.61 -$0.28
Diluted Earnings Per Share -$0.61 -$0.28
COMMON SHARES
Basic Shares Outstanding 57.06M 56.40M
Diluted Shares Outstanding 57.06M 56.40M

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $586.3M $505.2M
YoY Change 16.05% 97.81%
Cash & Equivalents $109.5M $32.56M
Short-Term Investments $476.7M $472.6M
Other Short-Term Assets $7.400M $11.30M
YoY Change -34.51% -6.61%
Inventory
Prepaid Expenses
Receivables $8.925M $10.13M
Other Receivables $800.0K $400.0K
Total Short-Term Assets $603.4M $527.0M
YoY Change 14.49% 95.55%
LONG-TERM ASSETS
Property, Plant & Equipment $16.24M $12.13M
YoY Change 33.9% 29.02%
Goodwill
YoY Change
Intangibles $15.16M $13.52M
YoY Change 12.13%
Long-Term Investments $1.100M $121.0M
YoY Change -99.09% -59.67%
Other Assets $8.788M $10.73M
YoY Change -18.07% 3475.33%
Total Long-Term Assets $41.33M $157.7M
YoY Change -73.8% -51.01%
TOTAL ASSETS
Total Short-Term Assets $603.4M $527.0M
Total Long-Term Assets $41.33M $157.7M
Total Assets $644.7M $684.8M
YoY Change -5.85% 15.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.51M $8.994M
YoY Change 16.89% 83.55%
Accrued Expenses $9.157M $6.226M
YoY Change 47.08% 5.53%
Deferred Revenue $44.69M $45.50M
YoY Change -1.79%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $66.45M $63.71M
YoY Change 4.3% -10.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.600M $13.00M
YoY Change -41.54% 1081.82%
Total Long-Term Liabilities $7.600M $13.00M
YoY Change -41.54% 1081.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $66.45M $63.71M
Total Long-Term Liabilities $7.600M $13.00M
Total Liabilities $74.08M $76.66M
YoY Change -3.37% 6.03%
SHAREHOLDERS EQUITY
Retained Earnings -$339.5M -$259.3M
YoY Change 30.94%
Common Stock $572.0K $565.0K
YoY Change 1.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $570.6M $608.1M
YoY Change
Total Liabilities & Shareholders Equity $644.7M $684.8M
YoY Change -5.85% 15.77%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$35.02M -$16.03M
YoY Change 118.4% -38.02%
Depreciation, Depletion And Amortization $1.400M $1.000M
YoY Change 40.0% 11.11%
Cash From Operating Activities -$27.70M $109.1M
YoY Change -125.39% -482.81%
INVESTING ACTIVITIES
Capital Expenditures -$1.600M -$2.500M
YoY Change -36.0% 56.25%
Acquisitions
YoY Change
Other Investing Activities $60.90M -$99.80M
YoY Change -161.02% -47.08%
Cash From Investing Activities $59.40M -$102.5M
YoY Change -157.95% -46.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.000M 3.900M
YoY Change 2.56% 69.57%
NET CHANGE
Cash From Operating Activities -27.70M 109.1M
Cash From Investing Activities 59.40M -102.5M
Cash From Financing Activities 4.000M 3.900M
Net Change In Cash 35.70M 10.50M
YoY Change 240.0% -104.85%
FREE CASH FLOW
Cash From Operating Activities -$27.70M $109.1M
Capital Expenditures -$1.600M -$2.500M
Free Cash Flow -$26.10M $111.6M
YoY Change -123.39% -514.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57214253
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56902301
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
dei Entity Registrant Name
EntityRegistrantName
Xencor Inc
dei Entity Central Index Key
EntityCentralIndexKey
0001326732
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity File Number
EntityFileNumber
001-36182
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
950000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1622502
dei Entity Address Address Line1
EntityAddressAddressLine1
111 West Lemon Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Monrovia
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91016
dei City Area Code
CityAreaCode
626
dei Local Phone Number
LocalPhoneNumber
305-5900
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
XNCR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
57242886
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109534000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50312000
CY2020Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
474114000
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
479470000
CY2020Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
2611000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8925000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21574000
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
804000
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
502000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7398000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6547000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
603386000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
558405000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16239000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15805000
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15162000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14421000
CY2020Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1145000
CY2019Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
71526000
CY2019Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
402000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8788000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9691000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
572000
CY2020Q2 us-gaap Assets
Assets
644720000
CY2019Q4 us-gaap Assets
Assets
670250000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10513000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10189000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9157000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8995000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2094000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2169000
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
44685000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45205000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
66449000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
66558000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7626000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8565000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1926000
CY2020Q2 us-gaap Liabilities
Liabilities
74075000
CY2019Q4 us-gaap Liabilities
Liabilities
77049000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57214253
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56902301
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
569000
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
908084000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
887873000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1483000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1161000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-339494000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-296402000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
570645000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
593201000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
644720000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
670250000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13089000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19485000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45474000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131424000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43458000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33299000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
77401000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61481000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7231000
us-gaap Operating Expenses
OperatingExpenses
72751000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-37600000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5758000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14449000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11270000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
50689000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
39057000
us-gaap Operating Expenses
OperatingExpenses
91850000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19572000
us-gaap Operating Income Loss
OperatingIncomeLoss
-46376000
us-gaap Operating Income Loss
OperatingIncomeLoss
58673000
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2090000
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3615000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5129000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6501000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2582000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3588000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3284000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6289000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35018000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15984000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43092000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
64962000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
492000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1845000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-212000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
950000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-35018000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-16034000
us-gaap Net Income Loss
NetIncomeLoss
-43092000
us-gaap Net Income Loss
NetIncomeLoss
64012000
CY2020Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
427000
CY2019Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1284000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
322000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
2600000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34591000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14750000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42770000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
66612000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57059610
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56399255
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57003162
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56351377
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57059610
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56399255
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57003162
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58042819
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
593201000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1471000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8179000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6512000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
593005000
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3275000
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
725000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34591000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8231000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
570645000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
521681000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
667000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
81361000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5856000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
609565000
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3239000
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
734000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14750000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9303000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
608091000
us-gaap Profit Loss
ProfitLoss
-43092000
us-gaap Profit Loss
ProfitLoss
64012000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2816000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2003000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
838000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1876000
us-gaap Share Based Compensation
ShareBasedCompensation
14743000
us-gaap Share Based Compensation
ShareBasedCompensation
15159000
us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
167000
us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
90000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4589000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1978000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-5000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-5000
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
153000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-12649000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-122000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-914000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
154000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
843000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
932000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
324000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5197000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
162000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3436000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
91000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1604000
xncr Increase Decrease In Lease Liabilities And Right Of Use Assets
IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets
-110000
xncr Increase Decrease In Lease Liabilities And Right Of Use Assets
IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets
-65000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2446000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
8699000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18222000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
90428000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
302319000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
244499000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1467000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2164000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2695000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1867000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
378454000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
159773000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
71973000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88757000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4746000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3906000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
725000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
734000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5471000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4640000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
59222000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6311000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50312000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26246000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109534000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32557000
us-gaap Interest Paid Net
InterestPaidNet
11000
us-gaap Interest Paid Net
InterestPaidNet
7000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
150000
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
322000
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
2600000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:36pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of interim financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, other comprehensive gain (loss) and the related disclosures. On an ongoing basis, management evaluates its estimates, including estimates related to its accrued clinical trial and manufacturing development expenses, stock-based compensation expense, intangible assets and related amortization. Significant estimates in these interim financial statements include estimates made for royalties and accrued research and development expenses, stock-based compensation expenses, intangible assets and related amortization, estimated standalone selling price of performance obligations, the likelihood of recognizing variable consideration, and recoverability of deferred tax assets.</p>
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56399255
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58042819
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57003162
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56351377
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1691442
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2019Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2020Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
xncr Marketable Securities Impairment Losses And Recoveries
MarketableSecuritiesImpairmentLossesAndRecoveries
0
CY2019Q2 xncr Marketable Securities Impairment Losses And Recoveries
MarketableSecuritiesImpairmentLossesAndRecoveries
0
xncr Marketable Securities Impairment Losses And Recoveries
MarketableSecuritiesImpairmentLossesAndRecoveries
0
CY2020Q2 xncr Marketable Securities Impairment Losses And Recoveries
MarketableSecuritiesImpairmentLossesAndRecoveries
0
CY2020Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
2611000
CY2020Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
581101000
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
583005000
CY2019Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-35018000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16034000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-43092000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
64012000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57059610
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2020Q2 us-gaap Investments
Investments
578490000
CY2020Q2 us-gaap Investments
Investments
578490000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57059610
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56399255
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57003162
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1173829
CY2020Q2 xncr Cash And Cash Equivalents And Marketable Securities Amortized Cost
CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost
576997000
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1496000
CY2019Q4 xncr Cash And Cash Equivalents And Marketable Securities Amortized Cost
CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost
581834000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1201000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
30000
CY2019Q4 us-gaap Investments
Investments
583005000
CY2019Q4 us-gaap Investments
Investments
583005000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
472639000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
474114000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
1127000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1145000
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
473766000
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
475259000
CY2020Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
300000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-2000000.0
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8231000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9303000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14743000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15159000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8231000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9303000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14743000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15159000
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1297000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2583000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2203000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1347000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1366000
CY2020Q2 xncr Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
1212000
CY2020Q2 xncr Lessee Operating Lease Liability Payments Due After Year Six
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
1238000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11246000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1526000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9720000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2094000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7626000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9720000
us-gaap Variable Lease Cost
VariableLeaseCost
57000
CY2020Q2 us-gaap Lease Cost
LeaseCost
686000
CY2019Q2 us-gaap Lease Cost
LeaseCost
697000
us-gaap Lease Cost
LeaseCost
1356000
us-gaap Lease Cost
LeaseCost
1356000
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
566000
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
344000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
648000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
650000
us-gaap Operating Lease Cost
OperatingLeaseCost
1297000
us-gaap Operating Lease Cost
OperatingLeaseCost
1299000
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
38000
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
47000
us-gaap Variable Lease Cost
VariableLeaseCost
59000
us-gaap Operating Lease Payments
OperatingLeasePayments
1123000
us-gaap Operating Lease Payments
OperatingLeasePayments
854000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
100000
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
100000
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13100000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19500000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45500000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131400000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13100000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19500000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45500000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131400000
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44700000
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
48800000
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45500000
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3300000

Files In Submission

Name View Source Status
0001558370-20-009191-index-headers.html Edgar Link pending
0001558370-20-009191-index.html Edgar Link pending
0001558370-20-009191.txt Edgar Link pending
0001558370-20-009191-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xncr-20200630.xsd Edgar Link pending
xncr-20200630x10q.htm Edgar Link pending
xncr-20200630x10q_htm.xml Edgar Link completed
xncr-20200630xex10d1.htm Edgar Link pending
xncr-20200630xex31d1.htm Edgar Link pending
xncr-20200630xex31d2.htm Edgar Link pending
xncr-20200630xex32d1.htm Edgar Link pending
xncr-20200630_cal.xml Edgar Link unprocessable
xncr-20200630_def.xml Edgar Link unprocessable
xncr-20200630_lab.xml Edgar Link unprocessable
xncr-20200630_pre.xml Edgar Link unprocessable